Cinclus Pharma Holding AB (publ) (OM: CINPHA)
Health Care · Pharmaceuticals · SE
Skr13.50
+4.33% today · -23.4% 1Y
Cinclus Pharma Holding AB (publ) (OM: CINPHA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $60.01M.
Over the last twelve months the share price has lost 23.4%, trading between 10.48 and 19.64.
Tweenvest scores Cinclus Pharma Holding AB (publ) across four factors: quality 38/100, value 43/100. Its strongest factor is value.
CINPHA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $60.01M
- Revenue (TTM)
- $3.63M
- P/E
- —
- EPS
- -5.25
- Dividend yield
- —
- Beta (5Y)
- 0.02
- 52-week high
- Skr19.64
- 52-week low
- Skr10.48
- Avg volume (3M)
- —
- Shares outstanding
- 46.54M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Theragen Etex Co.,Ltd.KOSDAQ: A066700 | $61.69M | ₩2,265.00 | +6.84% |
| TSH Biopharm Corporation LimitedTPEX: 8432 | $61.60M | NT$51.10 | +1.79% |
| CMG Pharmaceutical Co., Ltd.KOSDAQ: A058820 | $61.45M | ₩562.00 | +2.00% |
| Modern Chinese Medicine Group Co., Ltd.SEHK: 1643 | $61.02M | HK$0.67 | -2.21% |
| LTR Pharma LimitedASX: LTP | $59.38M | AU$0.47 | +5.62% |
| Citi Pharma LimitedKASE: CPHL | $59.29M | PKRs71.86 | -1.98% |
| Zhengye Biotechnology Holding LimitedNasdaqCM: ZYBT | $58.77M | $1.15 | -7.26% |
| Talphera, Inc.NasdaqCM: TLPH | $58.65M | $1.05 | -7.08% |
Figures last refreshed Oct 4, 2026.